Novus International Inc. has announced a strategic business realignment designed to accelerate innovation, strengthen operational agility and unlock long-term value for its global customer base. The transformation will result in two separate business units under the Novus umbrella – one dedicated to liquid methionine solutions and the other focused exclusively on specialty feed ingredients.
This new structure reflects Novus’s continued evolution as a science-driven, customer-focused company committed to helping producers achieve more. Both units will be structured as separate platforms, each with dedicated profit and loss accountability and the autonomy to focus on their core capabilities.
Novus CEO Dan Meagher will continue to lead the parent organization and provide strategic oversight across both businesses.
“Each unit now has the clarity and freedom to innovate faster, respond smarter and continue delivering solutions that meet the evolving needs of producers around the world,” Meagher said. “This is a bold, forward-thinking step that allows us to go further in our commitment to deliver value for our customers, our teams and our partners.”
Dave Dowell has been appointed president of the methionine business unit, while Ed Galo will lead the specialty business unit as president.
Novus has long been recognized for pioneering advancements in liquid methionine technology and for its leadership in specialty nutrition through intelligent feed solutions. The formation of these focused business units reinforces this leadership and unlocks new potential to scale innovations globally.
“This realignment is not a division -- it’s an evolution,” Meagher said. “An evolution that enables us to better serve the industry by doing what we do best: Deliver more science, more insight and more inspiration. This is how we continue to show the world that we’re made of more.”
Both business units will maintain uninterrupted service for dairy, poultry and swine producers globally.
